Results 41 to 50 of about 59,185 (303)

Evaluation of Recombinant Herpes Zoster Vaccine for Primary Immunization of Varicella-seronegative Transplant Recipients

Transplantation, 2021
Supplemental Digital Content is available in the text. Background. Immunization of varicella-zoster virus (VZV)-seronegative solid organ transplant (SOT) patients using the live-attenuated varicella vaccine is generally contraindicated, leaving no widely
MD Arnaud G. L'Huillier, MD Cedric Hirzel, PhD Victor H. Ferreira, Matthew Ierullo MSc, MSc Terrance Ku, MD Nazia Selzner, MD Jeffrey Schiff, MD Stephen Juvet, PhD Congrong Miao, PhD D. Scott Schmid, MD Atul Humar, Deepali Kumar   +11 more
semanticscholar   +1 more source

Avoiding rash decisions about zoster vaccination: insights from cost-effectiveness evidence

BMC Medicine, 2018
de Boer and colleagues present a cost-effectiveness analysis based in the Netherlands of two vaccines available for the prevention of herpes zoster. Zostavax® was the first vaccine available for the prevention of herpes zoster in older adults.
Chester B. Good, Natasha Parekh, Inmaculada Hernandez   +2 more
doaj   +1 more source

Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis

American journal of hematology/oncology, 2021
Monoclonal B‐cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL) are clonal B‐cell disorders associated with an increased risk of infections and impaired vaccination responses. We investigated the immunogenicity of recombinant zoster vaccine (
Eli Muchtar, A. Koehler, Michael J Johnson, K. Rabe, W. Ding, T. Call, J. Leis, Saad S. Kenderian, S. Hayman, Yucai Wang, P. Hampel, M. Holets, H. Darby, S. Slager, N. Kay, C. Miao, J. Canniff, J. Whitaker, M. Levin, D. Schmid, Richard B. Kennedy, A. Weinberg, S. Parikh   +22 more
semanticscholar   +1 more source

Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine

Human Vaccines & Immunotherapeutics, 2020
Herpes zoster (shingles) is a painful condition resulting from reactivation of latent varicella zoster virus (VZV). The Australian National Shingles Vaccination Program (commenced November 2016) provides free herpes zoster vaccination for eligible adults
John Litt, Robert Booy, Debra Bourke, Dominic E. Dwyer, Alan Leeb, Philip McCloud, Alicia N. Stein, Michael Woodward, Anthony L. Cunningham   +8 more
doaj   +1 more source

Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol. [PDF]

BMC Infect Dis
Hentzien M, Bonnet F, Bernasconi E, Biver E, Braun DL, Munting A, Leuzinger K, Leleux O, Musardo S, Prendki V, Schmid P, Staehelin C, Stoeckle M, Walti CS, Wittkop L, Appay V, Didierlaurent AM, Calmy A.   +17 more
europepmc   +3 more sources

Clinical features of varicella-zoster virus infection [PDF]

, 2018
Varicella-zoster virus (VZV) is a pathogenic human herpes virus that causes varicella (chickenpox) as a primary infection, following which it becomes latent in peripheral ganglia.
Gershon, Anne A., Kennedy, Peter G.E.
core   +1 more source

Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2019
Importance Herpes zoster, a frequent complication following autologous hematopoietic stem cell transplantation (HSCT), is associated with significant morbidity.
A. Bastidas, J. de la Serna, Mohamed El Idrissi, L. Oostvogels, P. Quittet, J. López-Jiménez, F. Vural, D. Pohlreich, T. Zuckerman, N. Issa, G. Gaidano, Je-Jung Lee, S. Abhyankar, C. Solano, J. Pérez de Oteyza, M. Satlin, S. Schwartz, M. Campins, A. Rocci, Carlos Vallejo Llamas, Dong‐Gun Lee, S. Tan, A. Johnston, A. Grigg, M. Boeckh, L. Cámpora, Marta López-Fauqued, T. Heineman, E. Stadtmauer, K. Sullivan   +29 more
semanticscholar   +1 more source

Comparison of the Immune Effects of an mRNA Vaccine and a Subunit Vaccine against Herpes Zoster Administered by Different Injection Methods

Vaccines, 2023
Previous studies have shown that the herpes zoster subunit vaccine Shingrix™ performs well in clinical trials. However, the key ingredient in its adjuvant, QS21, is extracted from rare plants in South America, so vaccine production is limited.
Kangyang Lin, Han Cao, Ning Luan, Yunfei Wang, Jingping Hu, Cunbao Liu   +5 more
doaj   +1 more source

Varicella paediatric hospitalisations in Belgium : a 1-year national survey [PDF]

, 2016
Background: Varicella universal vaccination (UV) has been implemented in many countries for several years. Nevertheless, varicella UV remains debated in Europe and few data are available on the real burden of infection.
Belgian Group for Varicella, the, Blumental, Sophie, Lepage, Philippe, Sabbe, Martine, Schelstraete, Petra   +4 more
core   +2 more sources

Recombinant zoster vaccine (Shingrix®): a new option for the prevention of herpes zoster and postherpetic neuralgia

The Korean Journal of Pain, 2020
Postherpetic neuralgia (PHN) is a challenging condition for pain management specialists. The prevention of herpes zoster (HZ) and subsequent PHN in individuals aged 50 years and older, via the development of new vaccines, is an ongoing research project ...
Grisuna Singh, Sejin Song, E. Choi, Pyung-Bok Lee, F. Nahm   +4 more
semanticscholar   +1 more source